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Aqueous extracts prepared from six South African medicinal plants, with cancer-related ethnobotanical uses, were tested for their cytotoxic
ability in vitro against three human cancer cell lines: DU-145 prostate cancer cells, MDA-MB-231 and MCF-7 breast cancer cells and a non-
malignant breast cell line, MCF-12A. The plants studied were: Bidens pilosa, Centella asiatica, Cnicus benedictus, Dicoma capensis, Hypoxis
hemerocallidea and Sutherlandia frutescens. Of these plants, only D. capensis exhibited pronounced cytotoxic effects in two of the cell lines
tested: MCF-7 and MCF-12A.
© 2006 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Cancer; Cytotoxity; Medicinal plants; South Africa1. Introduction
Reports on plants used for the treatment of cancer are rare in
South Africa. Mongelli et al. (2000) found this to be true for
Argentina plants, and ascribed it to the fact that cancer involves
a complex set of signs and symptoms. It has been recommended
that ethnopharmacological usages such as immune and skin
disorders, inflammatory, infectious, parasitic and viral diseases
be taken into account when selecting plants used to treat cancer,
since these reflect disease states bearing relevance to cancer or a
cancer symptom (Cordell et al., 1991; Popoca et al., 1998).
Since the majority of cancer chemotherapeutants severely
affect the hosts' normal cells (Mascarenhas, 1994), the use of
natural products has now been contemplated of exceptional
value in the control of cancer (Suffness and Pezzuto, 1990).
Furthermore, the search for new sources of biologically active
compounds is important for the discovery of new drugs for the
treatment of cancer.
This study determined the cytotoxic activities in aqueous
extracts of six plants used by traditional healers in South Africa
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Johannesburg) used in the treatment of prostate gland tumours
and inflammation (Watt and Breyer-Brandwijk, 1962; Hutch-
ings et al., 1996); (ii) Centella asiatica (L.) Urb. (Araliaceae,
South African National Biodiversity Institute (SANBI),
Tshwane) leaves which are prescribed for skin complaints,
rheumatoid arthritis, cancer and fevers (Watt and Breyer-
Brandwijk, 1962; Hutchings et al., 1996); (iii) decoctions of
Cnicus benedictus L. (Asteraceae, SANBI, Tshwane) taken
for the treatment of internal cancer (Watt and Breyer-Brandwijk,
1962; Van Wyk et al., 1997); (iv) leaves and twigs of Dicoma
capensis Less. (Asteraceae, gift from Prof. B-E van Wyk,
Department of Botany, Rand Afrikaans University) which are
prescribed in cases of cancer, high blood pressure and fever
(Van Wyk et al., 1997), (v) Hypoxis hemerocallidea Fisch. and
C.A. Mey. (Hypoxidaceae, Mai-Mai market, Johannesburg)
corms used to treat bladder disorders and testicular tumours
(Watt and Breyer-Brandwijk, 1962; Van Wyk et al., 1997) and
(vi) leaf decoctions of Sutherlandia frutescens (L.) R.Br.
(Fabaceae, provided by Dr. C. Albrecht, Medical Research
Council) which are taken for stomach problems, internal cancer,
inflammation and viral diseases (Watt and Breyer-Brandwijk,
1962; Rood, 1994; Van Wyk et al., 1997). Cytotoxicity was
determined against a prostate carcinoma cell line (DU-145),
breast cancer cell lines (MCF-7 and MDA-MB-231) and a non-
malignant breast cell line (MCF-12A).ts reserved.
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infusions prepared by traditional healers, therefore, only
aqueous extracts were tested in vitro. Dried plant material
(1 g) was suspended in 10 ml deionised water and brewed as a
tea by boiling for 15 min. Extracts were allowed to cool,
centrifuged and the supernatants passed through 0.45 μm and
0.22 μm filters, consecutively. The yields were 0.75%, 2.85%,
2.49%, 0.55%, 3.69% and 2.38% for B. pilosa, C. asiatica, C.
benedictus, D. capensis, H. hemerocallidea and S. frutescens,
respectively.
Human DU-145 prostate carcinoma cells were maintained in
Ham's F10 nutrient mixture supplemented with 5% decom-
plemented foetal calf serum (FCS), gentamycin sulphate
(0.004%), glucose (0.57%) and NaHCO3 (0.12%). MCF-12A
cells were cultured in a 1:1 mixture of Dulbecco's minimum
essential medium (DMEM) and Ham's F12 medium supple-
mented with epidermal growth factor (20 ng/ml), cholera toxin
(100 ng/ml), insulin (10 :g/ml), hydrocortisone (500 ng/ml) and
FCS (10%). MDA-MB-231 and MCF-7 breast carcinoma cells
were grown in DMEM supplemented with sodium pyruvate
(111 mg/l), sodium bicarbonate (2.25 g/l) and 10% FCS.
Cells were seeded into 96-well flat-bottomed plates at a
concentration of 3.0×105 cells per ml. After 24 h, cells were
treated with plant extract, which was diluted with culture
medium to a final concentration of 50 μg/ml (Zee-Cheng,
1997; Itharat et al., 2004). XTT labelling reagent (50 :l) was
added and the absorbance (560 nm) read after 72 h (Gerlier
and Thomasset, 1986). Experiments were carried out three
times in triplicate. Active extracts were considered as thoseFig. 1. The effect of 50 μg/ml plant extract on (A) DU-145 prostate cancer cells, (B)
12A non-malignant breast cells after an exposure time of 72 h; (A) Bidens pilosa; (B)
Cnicus benedictus; (F) Dicoma capensis. The values are expressed as means±S.E.Mwith less than 50% survival after an exposure time of 72 h.
Cisplatin, a known anti-tumour agent, was used as positive
control.
The effects of the plant extracts on proliferation in DU-145,
MDA-MB-231, MCF-7 and MCF-12A cells are presented in
Fig. 1A–D, respectively. Results showed B. pilosa to inhibit
proliferation by 10% in the carcinoma cell lines. Inhibition of
proliferation of leukemia cells in vitro has been reported with
hot water extracts of this plant (Chang et al., 2001). In four of
the five leukemia cell lines tested by these authors, the IC50
ranged between 145 and 200 μg/ml, concentrations 3–4 fold
above that tested in the present study. There are reports that
describe B. pilosa as having antiviral (Chiang et al., 2003), anti-
leukemic (Chang et al., 2001), anti-bacterial (Rabe and van
Staden, 1997), anti-malarial (Brandao et al., 1997), anti-
oxidative (Chiang et al., 2004), immunosuppressive and anti-
inflammatory activity (Jäger et al., 1996; Pereira et al., 1999).
The extracts of H. hemerocallidea stimulated DU-145 and
MCF-12A cell growth and inhibited the growth of the MCF-7
cells. This plant has been reported to display anti-inflammatory
activity (Ojewole, 2002), an activity related to cancer. The
aqueous extracts of S. frutescens inhibited growth of the
oestrogen dependent cancer cell lines and stimulated the growth
of the MCF-12A and MDA-MB-231 cells. Chinkwo (2005)
found the crude aqueous whole plant extract of S. frutescens to
induce cytotoxicity in cervical carcinoma and Chinese Hamster
Ovary cells. Ethanolic extracts of S. frutescens commercial
preparations (tablets and powder) have been reported to inhibit
proliferation of both MCF-7 and MDA-MB-468 human breastMDA-MB-231 breast cancer cells, (C) MCF-7 breast cancer cells and (D) MCF-
Hypoxis hemerocallidea; (C) Sutherlandia frutescens; (D) Centella asiatica; (E)
. (n=3).
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HL60 cells and murine RAW 264.7 macrophage/monocyte cells
(Tai et al., 2004). S. frutescens has been shown to possess anti-
oxidant potential (Fernandes et al., 2004), which is thought to
account for some of the anti-inflammatory properties already
known (Ojewole, 2004). In this study extracts of C. asiatica
stimulated the growth of three of the cell lines tested. Crude and
partially purified fractions of a methanolic extract of C. asiatica
have been reported to inhibit proliferation of transformed cell
lines (Ehrlich ascites tumour cells: IC50 62 μg/ml, Dalton's
lymphoma ascites tumour cells: IC50 75 μg/ml), and to be non-
toxic to normal human lymphocytes (Babu et al., 1995).
Antifungal, antibacterial, anti-inflammatory and anti-allergic
activity has been described for C. asiatica (Ponglux et al.,
1987). C. benedictus and D. capensis inhibited the proliferation
of DU-145, MCF-7 and MCF-12A cells. We found no literature
where the cytotoxic activity of C. benedictus or D. capensis has
previously been investigated.
The American National Cancer Institute guidelines set the
limit of activity for crude extracts at a 50% inhibition (IC50) of
proliferation of less than 30 μg/ml after an exposure time of 72 h
(Suffness and Pezzuto, 1990).With the exception ofD. capensis,
the other plant species had IC50 values higher than 50 μg/ml.
The IC50 values of the latter plant were 30 μg/ml and 31 μg/ml
in MCF-7 and MCF-12A cells, respectively. The positive con-
trol, cisplatin, had IC50 values of 0.27 μg/ml and 0.14 μg/ml in
MCF-7 and MCF-12A cells, respectively.
Some of the remedies investigated in this study have been
studied from a chemical point of view. The active substances of
H. hemerocallidea (rooperol), C. benedictus (cnicin, arctigenin,
arctiin) and S. frutescens (canavanine) are known to exhibit
tumouricidal or cytotoxic activity (Nicoletti et al., 1992; Hirano
et al., 1994; Southon, 1994; Swaffar et al., 1994; Moritani et al.,
1996). B. pilosa contains phenylheptatriyene which amongst
others kills human fibroblast cells (Morton, 1962). Asiaticoside
isolated from C. asiatica is reported to possess an IC50 of 1.58
±0.15 mg/ml in MCF-7 cells (Huang et al., 2004).
Since cytotoxicity of the plants investigated has been
reported by other authors, it is evident that different cell lines
exhibit different sensitivities towards the plant extracts. Also,
some plants are reported to have a cytotoxic effect on cancer
cells (Kusuge et al., 1985; Alley et al., 1988) whereas other
plant extracts activate several parameters of the immune system
as a strategy to destroy cancer (Abuharfeil et al., 2000).
Differences in results obtained in this study and those reported
in the literature could also be ascribed to differences in
extraction procedures and the natural variability in plants.
Since D. capensis showed the most pronounced cytotoxic
activity, this plant will be evaluated further for the possible
isolation of active compounds.Acknowledgements
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